Form 4: Century Therapeutics Officer Sells Shares for Tax Obligations

Century Therapeutics' Chief Technology and Manufacturing Officer, Gregory Russotti, sold 526 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Gregory Russotti, Chief Technology and Manufacturing Officer of Century Therapeutics, Inc. (IPSC), reported a sale of common stock.
• On December 8, 2025, Russotti sold 526 shares of common stock at a price of $0.532 per share.
• The sale was an automatic transaction to cover tax withholding obligations associated with the vesting of restricted stock units and was not at the discretion of the reporting person.
• Following this transaction, Russotti directly beneficially owns 390,982 shares and indirectly owns 92,773 shares through the Gregory Russotti 2021 Family Trust.

Sentiment

Score: 5

Explanation: Neutral. The transaction is a routine, non-discretionary sale to cover tax obligations associated with equity compensation, which is a common occurrence and does not reflect a change in management's view of the company's prospects.

Future Outlook

N/A

Management Comments

• The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Industry Context

This is a routine insider transaction for tax purposes and does not provide specific insights into broader industry trends or competitive landscape.

Related Party Transactions

• Gregory Russotti 2021 Family Trust indirectly owns 92,773 shares, representing a related party holding.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, non-discretionary sale for tax purposes and does not indicate a change in the officer's investment thesis or company fundamentals.
• Employees holding restricted stock units can expect similar tax withholding sales upon vesting.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary sale of shares by an officer to cover tax obligations related to restricted stock unit vesting. Such transactions are common and do not typically signal a change in the company's fundamental outlook or the officer's confidence. Therefore, it provides no new information that would warrant a change in investment recommendation based solely on this filing.

Keywords

Century Therapeutics, IPSC, Gregory Russotti, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, Officer Transaction